DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Fenoverine

Fenoverine

  • The Role of Antispasmodics in Managing Irritable Bowel Syndrome

    The Role of Antispasmodics in Managing Irritable Bowel Syndrome

  • A Four-Country Comparison of Healthcare Systems, Implementation

    A Four-Country Comparison of Healthcare Systems, Implementation

  • Clinical Trial Year Purpose Results Link Source Effects of Alverine

    Clinical Trial Year Purpose Results Link Source Effects of Alverine

  • (12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al

    (12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al

  • (12) Patent Application Publication (10) Pub. No.: US 2005/0203190 A1 Burgard Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2005/0203190 A1 Burgard Et Al

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • (NICE). Clinical Practice Guideline: Irritable Bowel Syndrome in Adults

    (NICE). Clinical Practice Guideline: Irritable Bowel Syndrome in Adults

  • (12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al

  • Effect of Antispasmodic Agents for the Treatment of Irritable Bowel Syndrome

    Effect of Antispasmodic Agents for the Treatment of Irritable Bowel Syndrome

  • Microsoft Word

    Microsoft Word

  • Bulking Agents, Antispasmodics and Antidepressants for the Treatment of Irritable Bowel Syndrome (Review)

    Bulking Agents, Antispasmodics and Antidepressants for the Treatment of Irritable Bowel Syndrome (Review)

  • CAPSULES Composition Packaging 6,15,10,Alu-Alu 10X10,15X15,Alu-Alu

    CAPSULES Composition Packaging 6,15,10,Alu-Alu 10X10,15X15,Alu-Alu

  • (12) Patent Application Publication (10) Pub. No.: US 2015/0050713 A1 Malakhov Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2015/0050713 A1 Malakhov Et Al

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • Orally Administered Pharmaceutical

    Orally Administered Pharmaceutical

  • Pharmaceuticals Appendix

    Pharmaceuticals Appendix

  • (Therapeutic Products) Regulations 2015

    (Therapeutic Products) Regulations 2015

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

Top View
  • Irritable Bowel Syndrome. Relevance of Antispasmodics
  • Transdermal Device Containing
  • Drug-Resin Complexes Stabilized by Chelating Agents
  • (12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
  • Customs Tariff - Schedule Xxi - 1
  • Australian Statistics on Medicines 2009
  • Medications, Dry Mouth and Dental Caries Among Older People: a Longitudinal Study
  • Literature Search Strategy for Treatment of Stable
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • A03 — Спазмолитики И Антихолинэргические Препараты Antispas
  • ICD-10-CM TABLE of DRUGS and CHEMICALS
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • A European Approach to Irritable Bowel Syndrome Management
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
  • Klasifikacija ATC 2021
  • ICD-10-CM Table of Drugs 2019
  • (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr


© 2024 Docslib.org    Feedback